Article info
PDFDTB select
Evidence for lecanemab in early Alzheimer’s disease
Citation
Evidence for lecanemab in early Alzheimer’s disease
Publication history
- First published February 1, 2023.
Online issue publication
February 22, 2023
Article Versions
- Previous version (1 February 2023).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© BMJ Publishing Group Limited 2023. No commercial re-use. See rights and permissions. Published by BMJ.